Evidence map›Paper›PMID 37639224›Full record

ArticleImmunoHorizons2023

Diplomate in Medical Laboratory Immunology Certification Examination: A New Chapter for Medical Laboratory Immunology.

Aaruni Khanolkar, Amy Spiczka, Tracey L Bonfield, Thomas S Alexander, John L Schmitz, Diana Boras, Karen Fong, Sarada L Nandiwada, Gerald C Miller, Anne E Tebo

Open access · goldAbstract read
In one paragraph

Article in ImmunoHorizons, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 2 countries.

Aaruni KhanolkarDepartment of Pathology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.ORCID 0000-0002-4442-8194
Amy SpiczkaAmerican Society for Clinical Pathology, Chicago, IL.
Tracey L BonfieldDepartment of Genomics and Genome Sciences & Pediatrics, Case Western Reserve University, Cleveland, OH.
Thomas S AlexanderIncite Health, Inc., Doylestown, PA.ORCID 0000-0002-7285-6241
John L SchmitzDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Diana BorasAmerican Society for Clinical Pathology, Chicago, IL.ORCID 0009-0001-4479-3343
Karen FongAmerican Society for Clinical Pathology, Chicago, IL.
Sarada L NandiwadaDepartment of Pediatrics, Section of Allergy & Immunology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX.ORCID 0000-0003-3344-1059
Gerald C Miller**Pathology Laboratory Associates, Tulsa, OK.
Anne E TeboDivision of Clinical Biochemistry and Immunology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.ORCID 0000-0001-9553-298X
American Society for Clinical Pathology · USBaylor College of Medicine · USCase Western Reserve University · USDoylestown Hospital · USMayo Clinic · USNorthwestern University · USUniversity of North Carolina at Chapel Hill · USUniversity of Tulsa · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is indeed a privilege to be an immunologist in what is arguably the golden age of immunology. From astounding advances in fundamental knowledge to groundbreaking immunotherapeutic offerings, immunology has carved out an enviable niche for itself in basic science and clinical medicine. The need and the vital importance of appropriate education, training, and certification in clinical immunology was recognized by the World Health Organization as far back as 1972. In the United States, Ph.D. scientists with board certification in medical laboratory immunology have served as directors of high-complexity Clinical Laboratory Improvement Amendments- and College of American Pathologists-certified clinical immunology laboratories since 1977. From 1977 to 2017, board certification for medical laboratory immunology was administered by the American Society for Microbiology through the American Board of Medical Laboratory Immunology examination. The American Board of Medical Laboratory Immunology examination was phased out in 2017, and in the fall of 2019, the American Society for Clinical Pathology (ASCP) Board of Certification (BOC) examination committee took on the responsibility of developing a new doctoral-level certification examination for medical laboratory immunology. This transition to the ASCP BOC represents a well-deserved and much-needed recognition of the rapid advances in and the highly specialized nature of medical laboratory immunology and its ever-increasing relevance to patient care. This new ASCP BOC certification is called the Diplomate in Medical Laboratory Immunology, and, as of April 1, 2023, it is now available to potential examinees. In this report, we describe the examination, eligibility routes, and potential career pathways for successful diplomates.

Indexed as

CertificationLaboratoriesHumans

Identifiers

PMID37639224
PMCPMC10587505
OpenAlexW4386209865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.